改良帕多瓦评分预测腹腔镜肾肿瘤射频消融术手术的风险  

Significance of a modified PADUA nephrometry score in predicting surgical risks during laparoscopic radiofrequency ablation of renal mass

作　　者：王鑫[1] 赵晓智[2] 吉鑫[2] 蒋银锋[2] 李笑弓[2] 甘卫东[2] 张古田[2] 张士伟[2] 郭宏骞[2] 

机构地区：[1]东南大学医学院,江苏南京210009 [2]南京大学医学院附属鼓楼医院泌尿外科,江苏南京210008

出　　处：《现代泌尿外科杂志》2015年第7期460-463,共4页Journal of Modern Urology

摘　　要：目的探讨帕多瓦(PADUA)评分是否能预测腹腔镜肾肿瘤射频消融术(LRFA)并发症发生的风险,根据LRFA本身的特点,改良PADUA评分系统,使其能够更好地预测LRFA的手术风险。方法回顾性分析160例单病灶肾肿瘤腹腔镜射频消融患者的临床资料,根据其术前CT进行标准的PADUA评分和改良PADUA评分(m-PADUA),分析这两种评分与手术并发症的相关性。结果标准的PADUA评分与LRFA并发症风险无明显相关性(P=0.307),而改良的PADUA评分与之有明显相关性(P=0.016)。结论标准的PADUA评分不适用于LRFA风险的预测,而改良评分能较好地预测LRFA手术风险。Objective To investigate whether the standard PADUA Nephrometry Score can predict complications after laparoscopic radiofrequency ablation（LRFA）,and to explore whether the modified PADUA score system（m-PADUA）is able to predict the risks.Methods Clinical data of 160 cases undergone single lesion LRFA were retrospectively analyzed.The preoperative CTResults were evaluated with the 2 systems,and then the correlation between the two scores and surgical complications were assessed.Results The standard PADUA Nephrometry Score had no obvious correlation with risk of complications（P=0.307）,but the modified PADUA score had a significant correlation（P=0.016）.Conclusions LRFA is a safe and effective treatment.The standard PADUA Nephrometry Score does not apply to LRFA risk prediction,while our modified score system can better predict LRFA operation risks.

关 键 词：肾癌 腹腔镜射频消融术 PADUA评分 改良 并发症 

分 类 号：R737.11[医药卫生—肿瘤]